Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
14cc of lidocaïne®----[1] 149 💬
29060X----[2] 13, 149 💬
3Anatomical Landmark-guided Suprascapular Nerve Block----[1] 149 💬
4Baclofen[1] Baclofen[1] Baclofen 💬[2] GABBR1,
GABBR2 💬		[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[8] 2, 10, 13, 18, 65, 70, 149, 206 💬
5Balance[1] Isoxaflutole---[5] 6, 11, 46, 81, 149 💬
6Botox[1] Botulinum toxin type A[1] Botulinum toxin type A 💬[1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[7] 2, 6, 13, 47, 51, 149, 226 💬
7Botulinum Toxin----[3] 6, 13, 149 💬
8Botulinum toxin A[1] Botulinum toxin type A[1] Botulinum toxin type A 💬[1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[4] 13, 51, 149, 226 💬
9BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[1] Botulinum toxin type A 💬[1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
10Brivaracetam[1] Brivaracetam[1] Brivaracetam 💬[1] SV2A 💬[1] ECM-receptor interaction 💬[2] 149, 309 💬
11Edonerpic[1] Edonerpic---[1] 149 💬
12FENFLURAMINE[1] Fenfluramine[1] Fenfluramine 💬[5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[4] 140, 144, 145, 149 💬
13Gradient----[1] 149 💬
14HC-58----[1] 149 💬
15Lacosamide[1] Lacosamide[1] Lacosamide 💬[2] SCN3A,
SCN9A 💬		[1] Taste transduction 💬[4] 2, 46, 149, 298 💬
16Medicinal air----[1] 149 💬
17MEOPA[1] Nitrous oxide[1] Nitrous oxide 💬--[1] 149 💬
18OnabotulinumtoxinA[1] Botulinum toxin type A[1] Botulinum toxin type A 💬[1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[4] 6, 13, 149, 226 💬
19Onabotulinumtoxina for Injection[1] Botulinum toxin type A[1] Botulinum toxin type A 💬[1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[1] 149 💬
20Oxybate[1] gamma-Hydroxybutyric acid---[2] 6, 149 💬
21Padsevonil[1] Padsevonil[1] Padsevonil 💬[3] SV2A,
SV2B,
SV2C 💬		[1] ECM-receptor interaction 💬[1] 149 💬
22Placebo----[28] 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
23Sodium Oxybate[2] Sodium oxybate,
gamma-Hydroxybutyric acid		[1] Sodium oxybate 💬--[2] 6, 149 💬
24SPM927----[1] 149 💬
25T-817MA----[1] 149 💬
26Time delay treatment of botulinum toxin----[1] 149 💬
27Triheptanoin[1] Triheptanoin[1] Triheptanoin 💬--[10] 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
28Ucb 34714----[2] 149, 309 💬
29Ultrasound-guided Suprascapular Nerve Block----[1] 149 💬
30Whole Exome Sequencing----[3] 65, 120, 149 💬